Don’t invest unless you’re prepared to lose all the money you invest. This is a high risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
A revolution in healthcare diagnostics:
non-contact,
non-invasive,
no consumables
Occuity is inventing optical handheld diagnostic devices for pain-free, non-contact screening - designed by a multi-award-winning team of engineers..
We are improving millions of lives by transforming detection and monitoring of glaucoma, myopia, diabetes and Alzheimer’s.
Crowdfunding now on Republic.
We're crowdfunding
Learn more about the Occuity crowdfunding round and how you can support us on the journey to better healthcare.
As Featured in:
Comfortable, handheld testing. Anytime, anywhere
We use a strong optical technology platform, protected by 15 patents and backed by over £4 million in grants, to build handheld, non-invasive devices that replace your painful tests with a quick, pain-free eye scan.
This proven platform supports many devices, helping us grow while staying well protected.
Revenue-backed growth with global reach
We are already experiencing early commercial success from our first product, the PM1 Pachymeter used for glaucoma screening, which is currently being sold through 19 distributors worldwide.
Next is the AX1 Axiometer, planned for 2026 to help manage myopia, a fast-growing condition expected to affect half the world by 2050—and this is only the start.
Non-invasive glucose monitoring is coming
We have a clear plan and product pipeline, and each new device builds on our optical platform, bringing us closer to our goal: an optical, non-invasive glucose meter for diabetes, the Occuity Indigo.
We are a British medical technology company with patents and growing sales—not just one product or an idea—and we have a plan to grow worldwide.
The team behind our success
Occuity is led by an experienced leadership team with multiple successful exits and decades of experience in optics, engineering, and medical device design.
And over the past few years we’ve assembled a talented team of award-winning scientists, designers and engineers who are passionate about turning cutting-edge research into real-world products that improve lives.
Dr. Dan Daly
CEO & Co-founder
.jpg)
Daniele De Iuliis
Design Director
Dr. Robin Taylor
CTO & Co-founder
Claire Mitchell
Head of Finance
Mark Jenkins
Chief Commercial Officer
Richard Kadri-Langford
Head of Marketing
Sharon Branch
Chief Operations Officer
Daniel Quirke
Non-Exec Director
Why are we crowdfunding?
Our next device — the AX1 Axiometer™ — is just months away from launch and is already attracting strong demand from distributors, clinicians and global myopia management providers. It represents a game-changing solution for the fast-growing myopia management market and is forecast to deliver rapid, scalable revenues.
This funding round will accelerate the AX1’s commercial rollout, scale manufacturing, and support the continued development of our optical platform — the foundation for our future Oculomics-based screening devices.
We're crowdfunding
Learn more about the Occuity crowdfunding round and how you can support us on the journey to better healthcare.
Don’t invest unless you’re prepared to lose all the money you invest. This is a high risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.